Biologics Commonly Used in Cutaneous Crohn's Disease

• by Andrea Surnit

• May 27, 2026

Dupilumab Gains Pediatric CSU Approval

Targets type 2 inflammation in a population with limited treatment options

• by Kathryn Wighton

• April 24, 2026

• 2 min

Cupping vs UVB: Comparable Psoriasis Outcomes?

Randomized study found no statistically significant differences in disease improvement between treatments over 8 weeks.

• by Meg Barbor

• April 9, 2026

• 2 min

Detecting comorbidity patterns in rare disease patients with machine learning

• by Benjamin Mark Connor, Claire Hill, Lu Bai, Amy Jayne McKnight, Anna Jurek-Loughrey

• May 4, 2026